Zura Bio (ZURA) Non-Current Assets (2021 - 2026)
Zura Bio (ZURA) posted quarterly Non-Current Assets of $1.6 million for Q1 2026, up 103.61% year-over-year from $804000.0 in Q1 2025, and little changed quarter-over-quarter from $1.6 million in Q4 2025.
Zura Bio (ZURA) Non-Current Assets (2021 - 2026) Analysis & Trends
Zura Bio's Non-Current Assets history runs 5 years deep, the most recent figure standing at $1.6 million for Q1 2026.
- In Q1 2026, Non-Current Assets rose 103.61% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $5.7 million (up 234.77% YoY), while the FY2025 annual figure was $1.6 million, up 107.6% from the prior year.
- Non-Current Assets for Q1 2026 stood at $1.6 million, roughly flat from $1.6 million in the prior quarter.
- The five-year high for Non-Current Assets was $140.3 million in Q3 2022, with the low at $9000.0 in Q1 2024.
- The 4-year median for Non-Current Assets is $1.6 million (2026), against an average of $33.1 million.
- The sharpest annual moves came in 2022 and 2025: Non-Current Assets sank 97.5% in 2022, then jumped 8833.33% in 2025.
- Zura Bio's Non-Current Assets stood at $3.5 million in 2022, then tumbled by 77.37% to $789000.0 in 2024, then surged by 107.6% to $1.6 million in 2025, then dropped by 0.06% to $1.6 million in 2026.
- Business Quant data shows ZURA's Non-Current Assets at $1.6 million in Q1 2026, $1.6 million in Q4 2025, and $1.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 14.88 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 23.28 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.96 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 294.93 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.96 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 18.06 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 938.60 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 468.65 Mn |
| 10 | Zura Bio | 706.30 Mn | 706.30 Mn | - | 2.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.90 Mn |
| Mar 31, 2026 | 1.64 Mn |
| Dec 31, 2025 | 1.64 Mn |
| Sep 30, 2025 | 1.64 Mn |
| Jun 30, 2025 | 820,000.00 |
| Mar 31, 2025 | 804,000.00 |
| Dec 31, 2024 | 789,000.00 |
| Sep 30, 2024 | 96,000.00 |
| Jun 30, 2024 | 25,000.00 |
| Mar 31, 2024 | 9,000.00 |
| Dec 31, 2022 | 3.49 Mn |
| Sep 30, 2022 | 140.28 Mn |
| Jun 30, 2022 | 139.60 Mn |
| Mar 31, 2022 | 139.42 Mn |
| Dec 31, 2021 | 139.40 Mn |